Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Pres & CEO - CooperSurgical | July 14, 2017 | July 14, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date July 14, 2017 · Filed July 14, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,352 |
Ending reported balance
After 2017-07-14 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2017-07-14 · Exercise / conversion · Acquired 6,186 · Balance 6,186 Row 2 · 2017-07-14 · Exercise / conversion · Acquired 3,122 · Balance 9,308 Row 3 · 2017-07-14 · Exercise / conversion · Acquired 1,338 · Balance 10,646 Row 4 · 2017-07-14 · Sale · Disposed 9,294 · Balance 1,352 F1: The sale price represents an average of sale prices between $248.1300 and $248.9100. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $95.74 · Expires 2022-12-11 | Direct | 4,124 |
Reported balance
After 2017-07-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-07-14 · Exercise / conversion · Disposed 6,186 · Balance 4,124 F2: 12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $119.89 · Expires 2023-12-11 | Direct | 4,683 |
Reported balance
After 2017-07-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-07-14 · Exercise / conversion · Disposed 3,122 · Balance 4,683 F3: 12/11/13 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/11/14; 1/5 shall vest on 12/11/15; 1/5 shall vest on 12/11/16; 1/5 shall vest on 12/11/17; and 1/5 shall vest on 12/11/18. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $162.28 · Expires 2024-12-09 | Direct | 5,351 |
Reported balance
After 2017-07-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-07-14 · Exercise / conversion · Disposed 1,338 · Balance 5,351 F4: 12/9/14 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/9/15; 1/5 shall vest on 12/9/16; 1/5 shall vest on 12/9/17; 1/5 shall vest on 12/9/18; and 1/5 shall vest on 12/9/19. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale price represents an average of sale prices between $248.1300 and $248.9100.
F2: 12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17.
F3: 12/11/13 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/11/14; 1/5 shall vest on 12/11/15; 1/5 shall vest on 12/11/16; 1/5 shall vest on 12/11/17; and 1/5 shall vest on 12/11/18.
F4: 12/9/14 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/9/15; 1/5 shall vest on 12/9/16; 1/5 shall vest on 12/9/17; 1/5 shall vest on 12/9/18; and 1/5 shall vest on 12/9/19.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2017 Filed Jul 14, 2017 20:21 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,338 | $0.00 Strike: $162.28 | $0.00 |
DisclosureSEC source: 0001127602-17-023606 · form4.xml · derivative · entry 7 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,351 Underlying: Common Stock · 1,338 shares Expires 2024-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 12/9/14 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/9/15; 1/5 shall vest on 12/9/16; 1/5 shall vest on 12/9/17; 1/5 shall vest on 12/9/18; and 1/5 shall vest on 12/9/19. Read SEC document |
| July 14, 2017 Filed Jul 14, 2017 20:21 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,122 | $0.00 Strike: $119.89 | $0.00 |
DisclosureSEC source: 0001127602-17-023606 · form4.xml · derivative · entry 6 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,683 Underlying: Common Stock · 3,122 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 12/11/13 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/11/14; 1/5 shall vest on 12/11/15; 1/5 shall vest on 12/11/16; 1/5 shall vest on 12/11/17; and 1/5 shall vest on 12/11/18. Read SEC document |
| July 14, 2017 Filed Jul 14, 2017 20:21 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,186 | $0.00 Strike: $95.74 | $0.00 |
DisclosureSEC source: 0001127602-17-023606 · form4.xml · derivative · entry 5 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,124 Underlying: Common Stock · 6,186 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17. Read SEC document |
| July 14, 2017 Filed Jul 14, 2017 20:21 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | SaleCommon Stock | 9,294 | $248.46 | $2,309,223.49 |
DisclosureSEC source: 0001127602-17-023606 · form4.xml · nonDerivative · entry 4 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,352 F1 · price: The sale price represents an average of sale prices between $248.1300 and $248.9100. Read SEC document |
| July 14, 2017 Filed Jul 14, 2017 20:21 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 1,338 | $162.28 | $217,130.64 |
DisclosureSEC source: 0001127602-17-023606 · form4.xml · nonDerivative · entry 3 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2017 Filed Jul 14, 2017 20:21 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 3,122 | $119.89 | $374,296.58 |
DisclosureSEC source: 0001127602-17-023606 · form4.xml · nonDerivative · entry 2 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2017 Filed Jul 14, 2017 20:21 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 6,186 | $95.74 | $592,247.64 |
DisclosureSEC source: 0001127602-17-023606 · form4.xml · nonDerivative · entry 1 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2017 Filed Apr 5, 2017 20:40 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | SaleCommon Stock | 3,605 | $199.99 | $720,973.68 |
DisclosureSEC source: 0001127602-17-014332 · form4.xml · nonDerivative · entry 1 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price represents an average of sale prices between $199.94 and $200.08 Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 22:18 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | SaleCommon Stock | 671 | $202.07 | $135,587.02 |
DisclosureSEC source: 0001127602-17-012977 · form4.xml · nonDerivative · entry 2 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 F2 · price: Sale price represents an average sale price between $202.0000 and $202.1286. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 22:18 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | SaleCommon Stock | 1,200 | $201.03 | $241,236.00 |
DisclosureSEC source: 0001127602-17-012977 · form4.xml · nonDerivative · entry 1 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,276 F1 · price: Sale price represents an average sale price between $201.0000 and $201.1201. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:06 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 814 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-003820 · form4.xml · derivative · entry 3 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 814 Underlying: Common Stock · 814 shares Expires not disclosed F3 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F4 · derivative.exercise_date: 2/1/2017 RSU Grant - Vest Date: The grant vests 100% on February 1, 2020. F5 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:06 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Tax withholdingCommon Stock | 765 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-003820 · form4.xml · nonDerivative · entry 2 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,476 F2 · shares: 2/1/2017 PSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 2/1/17) of $185.71 was used. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:06 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantCommon Stock | 2,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-003820 · form4.xml · nonDerivative · entry 1 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241 F1 · shares: 2/1/2017 PSU Release: Shares awarded on achievement of target level of performance under Performance Share Awards granted December 11, 2013 Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 401 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · derivative · entry 9 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204 Underlying: Common Stock · 401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F7 · derivative.exercise_date: 12/9/14 RSU Grant - Vesting Date: The grant vests in equal portions on the following dates: 1/8/16, 1/8/17, 1/8/18, 1/8/19 and 1/8/20. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · derivative · entry 8 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,086 Underlying: Common Stock · 544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F5 · derivative.exercise_date: Grant Date 12/11/13 RSU Vesting Date: The grant vests in equal portions on the following dates: 1/8/15, 1/8/16, 1/8/17, 1/8/18 and 1/8/19. F6 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · derivative · entry 7 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680 Underlying: Common Stock · 680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F3 · derivative.exercise_date: Grant Date 12/12/12 RSU Vesting Date: The grant vests in equal portions on the following dates: 1/8/14, 1/8/15, 1/8/16, 1/8/17 and 1/8/18. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Tax withholdingCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 6 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,016 F1 · shares: 1/8/2017 RSU/PSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/6/2017) of $177.21 was used. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 401 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 5 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Tax withholdingCommon Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 4 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,753 F1 · shares: 1/8/2017 RSU/PSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/6/2017) of $177.21 was used. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 3 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Tax withholdingCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 2 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,395 F1 · shares: 1/8/2017 RSU/PSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/6/2017) of $177.21 was used. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 1 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:55 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 1,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-070157 · form4.xml · derivative · entry 3 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,858 Underlying: Common Stock · 1,858 shares Expires not disclosed F3 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F4 · derivative.exercise_date: 12/13/16 RSU Grant - Vesting Date: The grant vests in equal portions on the following dates: 1/8/18, 1/8/19, 1/8/20, 1/8/21 and 1/8/22. F5 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:55 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantEmployee Stock Option (Right to Buy) · Derivative | 7,403 | $0.00 Strike: $175.31 | $0.00 |
DisclosureSEC source: 0001127602-16-070157 · form4.xml · derivative · entry 2 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,403 Underlying: Common Stock · 7,403 shares Expires 2026-12-13 F2 · derivative.exercise_date: 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.